MedEvidence! Truth Behind the Data
MedEvidence! Truth Behind the Data
Dr. Michael Koren
🎙 Alzheimer's Disease: The Hullabaloos of Aduhelm! Ep. 12
16 minutes Posted Apr 20, 2022 at 9:00 am.
0:00
16:31
Download MP3
Show notes

Send us a Text Message.

What's all the hullabaloos about Aduhelm, the first new Alzheimer's drug approval since 2003? This month's MedEvidence guest, Dr. Steven Toenjes, MD, a board-certified neurologist, former staff neurologist in the U.S. Navy and an award-winning director of neurology residents at the Uniformed Services University of Health Sciences and decorated Navy veteran joins Dr. Michael Koren and Michelle McCormick to discuss the first new Alzheimer's drug approval since 2003 and the controversy over FDA's approval of Biogen's Aducanumab (Aduhelm). 

If you enjoyed this episode, you will loves these:

Updated information on Medicare's decision to cover Alzheimer's drugs

Schedule a Free Memory Screening

Original Air Date: March 11, 2022

Be a part of advancing science by participating in clinical research

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn

Want to learn more checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Powered by ENCORE Research Group
Music: Storyblocks - Corporate Inspired

Thank you for listening!